Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia World Health Organization (WHO)
Source link
Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia World Health Organization (WHO)
Source link